nitazoxanide has been researched along with Hepatitis C in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, H; Murad, S; Neyts, J; Paeshuyse, J | 1 |
| Elazar, M; Gehrig, EA; Glenn, JS; Liu, M; Liu, P; McKenna, SA; Puglisi, JD; Rossignol, JF | 1 |
| Korba, B; Rossignol, JF; Viswanathan, P; Yon, C | 1 |
3 other study(ies) available for nitazoxanide and Hepatitis C
| Article | Year |
|---|---|
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries.
Topics: Antiviral Agents; Catechin; Food Additives; Genotype; Hepacivirus; Hepatitis C; Humans; Nitro Compounds; Prevalence; Silybin; Silymarin; Thiazoles; Virus Replication | 2016 |
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.
Topics: Antiparasitic Agents; Antiviral Agents; Cell Culture Techniques; Cell Line; eIF-2 Kinase; Eukaryotic Initiation Factor-2; Hepatitis C; Hepatocytes; Humans; Interferons; Nitro Compounds; Phosphorylation; Thiazoles | 2009 |
Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.
Topics: Antiviral Agents; Base Sequence; Cell Line; Cloning, Molecular; Drug Resistance, Viral; Escherichia coli; Genotype; Hepacivirus; Hepatitis C; Host-Pathogen Interactions; Humans; Interferons; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Nitro Compounds; Phenotype; Plasmids; Replicon; RNA, Viral; Thiazoles; Transformation, Bacterial; Viral Nonstructural Proteins; Virus Replication | 2011 |